Cisplatin hcc
WebSPRED2-knockout (KO)-HepG2 cells displayed an elongated spindle shape with increased cell migration/invasion and cadherin switching, with features of epithelial–mesenchymal transition (EMT). SPRED2-KO cells demonstrated a higher ability to form spheres and colonies, expressed higher levels of stemness markers and were more resistant to … WebSep 5, 2011 · Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma. Oncol Rep 23 : 965–972. CAS PubMed …
Cisplatin hcc
Did you know?
WebAug 24, 2012 · Cotreatment with cisplatin combined TRAIL-MSCs reduced vessel density in HCC. Tumors from control group, cisplatin group or TRAIL-MSCs group showed intense and diffuse CD34 immunoreactivity, whereas MVD … WebJan 4, 2011 · The purpose of this retrospective study was to investigate the efficacy of transarterial chemoembolization (TACE) using cisplatin as a second-line treatment for advanced hepatocellular carcinoma (HCC) unresponsive to TACE using epirubicin–Lipiodol emulsion at our institution. Materials and Methods
WebSep 7, 2016 · To enhance the antitumor activity, gemcitabine was combined with cisplatin. Gemcitabine plus cisplatin demonstrated modest clinical activity (25% objective … WebMar 14, 2024 · Previous studies revealed that high oxidored-nitro domain-containing protein 1(NOR1) expression in HCC was associated with cisplatin (DDP) resistance. Herein, a …
WebJul 1, 2024 · This is a study of pembrolizumab plus gemcitabine/cisplatin versus placebo plus gemcitabine/cisplatin as first-line therapy in participants with advanced and/or unresectable biliary tract carcinoma. The primary hypothesis is pembrolizumab plus gemcitabine/cisplatin is superior to placebo plus gemcitabine/cisplatin with respect to … WebFeb 1, 2024 · Hepatocellular carcinoma (HCC) is the fourth major contributor to cancer-related deaths worldwide, and patients mostly have poor prognosis. Although several …
WebApr 1, 2024 · 条件:Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Hepatocellular Cancer, Liver Cancer, Liver, Cancer of, Non-Resectable NCT04965714 取消 . …
WebFeb 20, 2024 · Advances of targeted therapies and immunotherapy – Since 2008, there has been a resurgence of interest and enthusiasm for systemic therapy of HCC with the … how many kg is a solar massWebMar 31, 2016 · View Full Report Card. Fawn Creek Township is located in Kansas with a population of 1,618. Fawn Creek Township is in Montgomery County. Living in Fawn … how many kg is in a newtonWebCisplatin is also used alone or in combination with other medications to treat bladder cancer that can not be treated with surgery or radiation therapy alone. Cisplatin is in a class of … howard miller small mountable clockWebOn September 2, 2024, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca UK Limited) in combination with gemcitabine and cisplatin for adult patients with locally advanced... howard miller small mantel clockWebCancer cell resistance to chemotherapy drugs such as Gemcitabine, Oxaliplatin, Cisplatin, Doxorubicin, and 5-fluorouracil account for the main reason of chemotherapy failure for HCC patients, especially for those with advanced HCC or metastasis patients. howard miller small wall clocksWebMay 7, 2024 · The LI-RADS score for a liver lesion is an indication of its relative risk for hepatocellular carcinoma (HCC). The classification system is meant to be used in livers which have risk factors for HCC (e.g. cirrhotic livers ). The original LI-RADS was developed for extracellular gadolinium contrast agents (e.g. Gadavist ). howard miller state parkWebHepatocellular carcinoma (HCC) is one of the most lethal malignancies worldwide. However, the immune tolerance limits the effect of chemotherapeutic drugs. Therefore, … howard miller sonoma ii wine \u0026 bar cabinet